Σύγκριση μεθόδων

	Ερωτηματολόγιο EORTC QLQ-BR23: Ποιότητα Ζωής στον Καρκίνο του Μαστού	FACT-Lung: Λειτουργική Αξιολόγηση Θεραπείας του Καρκίνου
Πεδίο	Ογκολογία	Ογκολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1996	1995
Δημιουργός	Sprangers, M. A., et al. (EORTC Quality of Life Group)	David F. Cella, Ph.D.
Τύπος	Self-report questionnaire	Self-report questionnaire
Θεμελιώδης πηγή	Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Εναλλακτικές ονομασίες	QLQ-BR23	FACT-L
Συναφείς	5	5
Σύνοψη	The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.